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Nephrology in China: A great mission and momentous challenge. 1980s that it was recognized as an independent discipline
Nephrological work in China started in early 60s, but it was not and links developed with the international nephrology
until the middle of the 1980s before it became an independent community. The first committee of the Chinese Societydiscipline and linked with the international nephrology com-
of Nephrology (CSN) was established in 1980 and the So-munity. Due to the huge population and enormous territory,
nephrologists are facing a great mission and momentous chal- ciety held its first academic congress in 1982. The Chinese
lenges. Most nephrologists reside in the coastal region, which Journal of Nephrology was first formally published in
has a higher education background than most of the rest of the Guangzhou in 1985. Efforts to develop a complete regis-country. Among them, Beijing, Shanghai, Guanzhong and Nang-
tration system for dialysis and transplantation in Chinajing are the major centers for training graduate students to
began in 1998.conduct basic and clinical research. Renal biopsy is widely per-
formed in China. IgA nephropathy is the leading cause among Nephrologists are faced with a great mission and mo-
the primary causes of glomerulonephritis that are diagnosed mentous challenges in China, a vast country with a huge
by renal biopsy, while lupus nephritis is the most prominent
population of 1.3 billion and a broad territory of 9.6among the causes of second glomerulopathy. Though diabetic
million square kilometers.nephropathy now constitutes only about 10% of the cause of
secondary glomerulopathy, the rapid rise of diabetes mellitus
predicts a future prominent role of this disease in managing
progressive renal failure in China. Both hemodialysis and peri- WORK FORCE AND TRAINING
toneal dialysis are widely used in China, with approximately
Because of the dictates of the distribution patterns ofa 40 to 50% survival rate in three years. About two thirds of
the end-stage renal disease (ESRD) patients received erythro- the population, and the more advanced education stan-
poietin; however, the hematocrit levels of most cases are less dards in the coastal region, most of the registered nephrol-
ideal. A variety of sources, mainly from the government, in sev-
ogists are gathered there. The number of nephrologists,eral big cities provide financial support for ESRD dialysis,
including those in training grades, in Beijing, Shanghaiwhich has already become a heavy burden to public health.
About 5000 patients receive renal transplantation every year and Guangzhou are equivalent to at least 30 per million
in which the organs are mainly from brain dead cadavers. Renal of the population [1]. Among the registered nephrolo-
disease registration has been established since 1999. Control- gists, 15% have been specifically trained through post-ling the high incidence of diabetes and early treatment, studying
graduate courses. In Beijing and Shanghai, more thanthe genetic and environmental mechanisms possibly related to
the high incidence of IgA nephropathy in rural areas, and 30% of the nephrologists hold masters degrees or doctor-
establishing a nationwide network to apply guidelines for dial- ates. The latter are classified as clinical or research based.
ysis and transplantation in a fashion relevant to real situations Those gaining the latter classification tend to specializein China are major challenges to the Chinese nephrologists.
thereafter in basic renal research.
Residents who have completed three years training in
general medicine thereafter may gain further experienceThe practice of nephrology commenced in China in
in specialized renal units. They are required to completethe late 1950s. For a period of about 12 years, from the
their renal training in one of the major institutions inmid 1960s until the late 1970s, because of changes in the
Beijing, Shanghai, Guangzhou or Nanjing. As yet there iswider political scenario, there were no further develop-
no specialized renal qualification that can be gained by anments in nephrological practice. It was not until the mid
examination, thesis or completion of a training program.
Since 1995 the International Society of Nephrology has
Key words: ESRD, hemodialysis, China, training, dialysis. taken an active role in organizing continuing medical
education (CME) courses in China. 2003 by the International Society of Nephrology
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TRAINING OVERSEAS bulatory peritoneal dialysis (CAPD). In small centers
where there are fewer special facilities, peritoneal dial-About 30% of nephrologists who have gained post-
ysis is more commonly employed. In larger cities, be-graduate qualifications travel overseas for further post-
cause of the relatively high cost of imported fluid fordoctoral training. Thirty percent return to China. Of the
CAPD, which means that the costs are roughly equiva-nephrologists with a principle commitment to clinical
lent, hemodialysis is now and is likely to remain thepractice, about one fifth have the opportunity of traveling
predominant mode of treatment. At the present timeabroad for further study, usually for shorter periods of
about 80% of patients are treated by maintenance hemo-six to twelve months. Most return to China to work.
dialysis and 20% by CAPD. There is universal use of
twin bag systems for CAPD in the major centers.CLINICAL NEPHROLOGY
The two and three year survival rates for dialysis pa-
Renal biopsy is widely performed in the major renal tients are 50% and 40%, respectively. About 20% of pa-
centers in China. Until 1999, 100,000 such cases had been tients survive for more than five years with a small num-
detailed, the majority in recent years [2]. Many hospitals ber living for more than ten years. The average frequency
have nephrologists on staff who also have their own renal of dialysis is 2.3 times per week. The adequacy of dialysis
pathology laboratory, and tissue is routinely examined by
(Kt/V) ranges from 1.2 to 1.6 for hemodialysis.
light and fluorescence microscopy. Electron microscopic
In Shanghai, two thirds of ESRD patients are treatedanalysis is available in hospitals affiliated with medical
with erythropoietin (EPO). Although there are more thanschools. Thus, a tissue diagnosis can be obtained promptly
20 bio-pharmaceutical companies producing recombi-for the management of cases such as rapidly progressive
nant human EPO (rHuEPO) in China, and the pricingglomerulonephritis or acute rejection following trans-
is competitive—about one third of the cost of importedplantation.
products—the hematocrit levels of most cases are less thanIn China today, though, the natural history of many re-
ideal (average 28.2%). Aside from issues of availability,nal diseases has still not been demarcated, but the inci-
one of the more important reasons may be reduced re-dence of possibly associated infectious diseases has fallen
sponsiveness, as intravenous iron preparations have nottremendously. The incidence of hepatitis virus-related
been available in mainland China.disease is still high. The positive detection rate for hepati-
The leading cause of death among patients with ESRDtis B antigen on renal biopsy tissue is about 5 to 7%.
is cardiovascular disease, accounting for 57% of 4010Only incomplete statistics are available, but among
cases. For patients on CAPD the main cause is death isthe primary causes of glomerulonephritis diagnosed by
as a result of infection.renal biopsy, IgA nephropathy is the leading cause, rang-
ing from 30 to 40% of cases undergoing biopsy, and The financial support for dialysis comes mainly from
the incidence is still rising. Lupus nephritis is the most Government sources. Government employees, those who
prominent among the causes of secondary glomerulopa- work for Government owned enterprises and those who
thy, which is in contrast to the findings in many developed can obtain enrollment in the Government Health Insur-
countries. Currently diabetic nephropathy constitutes ance Program are able to gain reimbursement for the
10% of the cases of secondary glomerulopathy. Nonethe- costs of their treatment. In the large cities, in Shanghai
less, the rising incidence of diabetes (statistics for Shang- for instance, more than two thirds of the patients with
hai show an incidence of 0.7% in 1965; 1.7% in 1985; ESRD are available to afford the cost of dialysis by ob-
and 1.9% in 1999) and the increasing proportion of cases taining financial support from a variety of sources. Due
of end-stage renal disease (ESRD) apparently caused to the increasing number of ESRD cases and hence the
by diabetes (4.9% in 1985; 10.6% in 1999 and 17.6% in increasing expense, the upper limit of financial support
2000), and the increasing obesity in Shanghai and other for the cost of dialysis has been capped by the Govern-
major cities (30% in children aged 8 to 12 in 2000 in ment in most areas of the country. The average cost for
Shanghai) suggest that the future predominance of dia- hemodialysis in Shanghai is US$7500 per patient per
betes among cases of progressive renal failure in China year and US$9600 for peritoneal dialysis. These rates
is assured, much as is the case in Western nations.
are clearly much cheaper than those available in more
developed nations. Nonetheless, this is still a heavy bur-
DIALYSIS den on the public health and social security systems.
The principle reason for non-acceptance onto dialysisIn the relatively economically developed areas of China,
programs is the inability to afford treatment for thoseespecially in the major cities, the incidence of ESRD is
who do not have access to insurance programs. It is nowcurrently estimated to be 102 cases per million of the pop-
quite rare to find areas in China where dialysis is notulation. Fifty-five percent of these patients are currently
receiving hemodialysis or treatment with continuous am- available for lack of trained staff and facilities.
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RENAL TRANSPLANTATION in clinical nephrology. Funding from the Ministry of Edu-
cations supports doctorate training in the universities.While most of the recipients of renal transplants are
There is intense competition for these sources of funding.young, an inability to pay for the procedure is still a bar-
As in other parts of world, promotion in nephrology isrier to transplantation. For those with access to medical
closely linked to success in the pursuit and publicationinsurance, reimbursement of $100,000 Yuan (US$12,000)
of research. Funding also is directed toward researchis available for the first year of treatment following trans-
into nephrological aspects of traditional Chinese medi-plantation. Cyclosporine, which is locally produced, to-
cine. As China’s economy has strengthened, so the fundsgether with mycophenolate mofetil and prednisolone
available for research have increased, particularly in theconstitute the most widely used immunosuppressive re-
area of basic science.gime, but tacrolimus and sirolimus also are available for
use, and the cost of these agents can be reimbursed also.
Monoclonal antibodies are available, but the cost of their INTO THE FUTURE
use is not reimbursed. The future priorities for the nephrological community
Renal transplantation units are not Government run, in China include: enhanced advocacy of lifestyle modi-
and a number of private clinics are being established to fication, aiming to reign in the increasing incidence of
provide the necessary services. The principle source of or- diabetes; acquisition of much more complete epidemio-
gans is from brain dead cadavers. There are laws enacted logical data in relation to progressive renal disease; the
to govern this process and there is strict adherence to promotion of registries for processing information relat-
these in the major cities. Signed consent is required from ing to dialysis and transplantation; the subsequent dis-
the closest relative and in the case of renal donation fol- semination of information about renal disease among the
lowing execution, from the donor and the closest relative. Chinese people; further studying the genetic and envi-
There were 5040 transplant operations in 2000 and ronmental mechanisms of common clinical problems that
4130 in 2001. Less than 10% of these were from living are found in high prevalence, such as hepatitis B and IgA
related sources. The 12 month graft survival is 80%, nephropathy; enhancing the care programs for common
although there are regional differences. These and other diseases such as lupus nephritis; intensifying and ex-
related data are published annually by the Chinese Dial- panding the training programs for nephrology, especially
ysis and Transplantation Association [3]. Renal trans- in rural areas; and establishing an efficient nationwide
plantation is performed by specialist surgeons, most of nephrology network that will have as one of its important
whom have a background in urology. activities the formulation and modification of diagnostic
and therapeutic guidelines. This would include guide-
lines for hemodialysis, peritoneal dialysis and renal trans-DISEASE REGISTRATION
plantation in a fashion that is relevant for modern China.
The registration system has been established, although
Reprint requests to Shanyan Lin, M.D., Division of Nephrology,it is still in its infancy and the available data are incom-
Department of Medicine, Shanghai Medical University, Hua Shan Hos-
plete. Data for the years 1999 and 2000 were published pital, Shanghai 200040, Peoples Republic of China.
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